NEOMYCINE 50 COOPHAVET
NEOMYCINE 50 COOPHAVET
Authorised
- NEOMYCIN SULFATE
Product identification
Medicine name:
NEOMYCINE 50 COOPHAVET
Active substance:
- NEOMYCIN SULFATE
Target species:
-
Cattle
-
Pig (piglet)
-
Rabbit
-
Sheep (lamb)
-
Sheep
-
Goat (kid)
-
Goat
-
Cattle (calf)
-
Poultry
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
NEOMYCIN SULFATE500000.00international unit(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Milkno withdrawal periodLa spécialité n'est pas destinée aux femelles laitières productrices de lait de consommation).
-
- Pig (piglet)
-
Meat and offal14day
-
- Rabbit
-
Meat and offal14day
-
- Sheep (lamb)
-
Meat and offal14day
-
- Sheep
-
Milkno withdrawal periodLa spécialité n'est pas destinée aux femelles laitières productrices de lait de consommation).
-
- Goat (kid)
-
Meat and offal14day
-
- Goat
-
Milkno withdrawal periodLa spécialité n'est pas destinée aux femelles laitières productrices de lait de consommation).
-
- Cattle (calf)
-
Meat and offal14day
-
- Poultry
-
Meat and offal14day
-
Eggs0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Dopharma France S.A.S.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dopharma France
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/0359766 8/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?: